Medication info
Zabia Tablet 100 mg (Sitagliptin Hydrochloride Monohydrate)

Zabia Tablet 100 mg (Sitagliptin Hydrochloride Monohydrate)

Prescription medicationTablet
Ingredient · strength
Sitagliptin Hydrochloride Hydrate›113.4mg / 1 tablet
Manufacturer / importer
Unimed Pharmaceuticals, Co., Ltd.
Appearance
Orange, double-convex, round film-coated tablet
Packaging
30 tablets/box [10T/PTP*3]
Approval status
Active

MFDS item code 202301944 · Approved 2023.06.26 · Insurance code 649508330

Summary

Main use
Improvement of glycemic control in type 2 diabetes mellitus
Who uses it
Adults
Adult dosage
Administer 100 mg once daily as monotherapy or in combination therapy; the maximum daily dose is 100 mg. This medication may be taken with or without food. When administered with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia induced by the sulfonylurea or insulin (see Precautions for Use, 5. General Precautions). Patients with renal impairment Because dosage adjustment according to renal function is required, assessment of renal function before and periodically during treatment with this medication is recommended. 1. No dose adjustment is necessary in patients with mild renal impairment (glomerular filtration rate [eGFR] ≥ 60 mL/min/1.73 m2 and < 90 mL/min/1.73 m2). 2. No dose adjustment is necessary in patients with moderate renal impairment (glomerular filtration rate [eGFR] ≥ 45 mL/min/1.73 m2 and < 60 mL/min/1.73 m2). 3. Administer 50 mg once daily in patients with moderate renal impairment (glomerular filtration rate [eGFR] ≥ 30 mL/min/1.73 m2 and < 45 mL/min/1.73 m2). 4. Administer 25 mg once daily in patients with severe renal impairment (glomerular filtration rate [eGFR] ≥ 15 mL/min/1.73 m2 and < 30 mL/min/1.73 m2) or end-stage renal disease (ESRD) requiring hemodialysis or peritoneal dialysis (glomerular filtration rate [eGFR] < 15 mL/min/1.73 m2). This medication may be administered without regard to the timing of dialysis.

Ingredients

Manufacturer
Unimed Pharmaceuticals, Co., Ltd.

Efficacy & effects

Improvement of glycemic control in type 2 diabetes mellitus

  • Abnormal blood sugar control in patients with type 2 diabetes
View approved original text

This medication aids in improving blood sugar control for patients with type 2 diabetes by supplementing dietary and exercise therapy. It can be used alone or in combination with other medications as needed, assisting in effective blood sugar regulation.

Dosage and Administration

Adult dosage

Administer 100 mg once daily as monotherapy or in combination therapy; the maximum daily dose is 100 mg. This medication may be taken with or without food. When administered with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia induced by the sulfonylurea or insulin (see Precautions for Use, 5. General Precautions). Patients with renal impairment Because dosage adjustment according to renal function is required, assessment of renal function before and periodically during treatment with this medication is recommended. 1. No dose adjustment is necessary in patients with mild renal impairment (glomerular filtration rate [eGFR] ≥ 60 mL/min/1.73 m2 and < 90 mL/min/1.73 m2). 2. No dose adjustment is necessary in patients with moderate renal impairment (glomerular filtration rate [eGFR] ≥ 45 mL/min/1.73 m2 and < 60 mL/min/1.73 m2). 3. Administer 50 mg once daily in patients with moderate renal impairment (glomerular filtration rate [eGFR] ≥ 30 mL/min/1.73 m2 and < 45 mL/min/1.73 m2). 4. Administer 25 mg once daily in patients with severe renal impairment (glomerular filtration rate [eGFR] ≥ 15 mL/min/1.73 m2 and < 30 mL/min/1.73 m2) or end-stage renal disease (ESRD) requiring hemodialysis or peritoneal dialysis (glomerular filtration rate [eGFR] < 15 mL/min/1.73 m2). This medication may be administered without regard to the timing of dialysis.

Precautions

This medication may cause serious allergic reactions after administration; therefore, if symptoms such as skin rash, difficulty breathing, or swelling of the face or neck occur, discontinue use immediately and consult a doctor. There is a potential for developing serious pancreatic inflammation known as acute pancreatitis during the use of this medication. If symptoms such as abdominal pain, vomiting, or persistent nausea occur, it is crucial to seek immediate medical attention. Patients with type 1 diabetes or diabetic ketoacidosis should not use this medication, and those with allergies to this drug or its components should also avoid it. Patients with impaired kidney function should adjust the dosage of this medication and undergo regular kidney function tests. This medication can be used alone or in conjunction with other diabetes treatments, but caution is required when used with insulin or sulfonylureas, as there may be an increased risk of hypoglycemia. During treatment, side effects such as headache, upper respiratory infection, nasopharyngitis, diarrhea may occur; if symptoms are severe or persistent, consult a doctor. Rare side effects such as severe arthralgia or blistering conditions resembling bullous pemphigoid have been reported; discontinue use immediately and consult a specialist should these symptoms occur. Use of this medication is not recommended for pregnant or breastfeeding women, and the safety and efficacy in children under 18 years have not been established. In cases of overdose, management to remove the drug from the gastrointestinal tract and monitor conditions such as electrocardiograms may be necessary, and this medication can be partially removed by hemodialysis. This medication has minimal interactions with other medications, but careful monitoring is required when used with digoxin. Elderly patients may experience decreased kidney function, making dosage adjustment and kidney function testing important.

Side effects

  • Severe allergic reactions
  • anaphylaxis
  • angioedema
  • Stevens-Johnson syndrome
  • exfoliative skin disease
  • acute pancreatitis
  • hypoglycemia
  • nasopharyngitis
  • upper respiratory tract infections
  • headache
Show 34 more
  • diarrhea
  • abdominal pain
  • nausea
  • peripheral edema
  • constipation
  • vomiting
  • severe and disabling arthralgia
  • vesicular pemphigoid
  • myalgia
  • limb pain
  • back pain
  • interstitial lung disease
  • pruritus
  • thrombocytopenia
  • rhabdomyolysis
  • elevated liver enzymes
  • acute renal failure
  • pneumonia
  • diabetes complications
  • metabolic acidosis
  • falls
  • cardiac arrest
  • dyspepsia
  • dizziness
  • elevated ALT
  • elevated AST
  • increased blood triglycerides
  • gastritis
  • increased low-density lipoprotein
  • hyperglycemia
  • weight loss
  • hypertension
  • hypernatremia
  • erectile dysfunction

Not everyone experiences these, and they can vary from person to person.

Storage

Store this medication in a tightly sealed container to prevent air and moisture exposure. It is advisable to maintain a storage temperature between 1 and 30 degrees Celsius at room temperature to ensure the efficacy and safety of the medication.

Appearance and packaging

Appearance

Orange, double-convex, round film-coated tablet

Package unit

30 tablets/box [10T/PTP*3]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.